Weidai Stock Forecast, Price & News

Weidai's stock was trading at $1.46 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, WEI stock has decreased by 36.3% and is now trading at $0.93.
View which stocks have been most impacted by COVID-19.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Weidai in the last year. There are currently 2 sell ratings for the stock, resulting in a consensus recommendation of "Sell."
View analyst ratings for Weidai.

Weidai is scheduled to release its next quarterly earnings announcement on Wednesday, September 23rd 2020.
View our earnings forecast for Weidai.

Weidai Ltd (NYSE:WEI) announced its quarterly earnings results on Wednesday, May, 27th. The company reported ($1.14) earnings per share for the quarter, missing the Zacks' consensus estimate of $1.55 by $2.69. The firm earned $101.54 million during the quarter. Weidai had a net margin of 7.55% and a return on equity of 7.93%.
View Weidai's earnings history.

2 brokers have issued twelve-month price targets for Weidai's shares. Their forecasts range from $5.40 to $5.40. On average, they anticipate Weidai's stock price to reach $5.40 in the next year. This suggests a possible upside of 480.6% from the stock's current price.
View analysts' price targets for Weidai.

Weidai saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 32,600 shares, an increase of 40.5% from the August 15th total of 23,200 shares. Based on an average daily trading volume, of 58,800 shares, the short-interest ratio is currently 0.6 days.
View Weidai's Short Interest.

Some companies that are related to Weidai include Yirendai (YRD), America First Multifamily Investors (ATAX), CNFinance (CNF), Jiayin Group (JFIN), 9F (JFU), Security National Financial (SNFCA), Velocity Financial (VEL), On Deck Capital (ONDK), Elevate Credit (ELVT), X Financial (XYF), Consumer Portfolio Services (CPSS), Fincera (YUANF), Medallion Financial (MFIN), Golden Bull (DNJR) and Golden Bull (BTBT).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Weidai investors own include AbbVie (ABBV), Carnival (CCL), Energy Transfer LP Unit (ET), American Airlines Group (AAL), Baidu (BIDU), Corbus Pharmaceuticals (CRBP), NIO (NIO), Ovid Therapeutics (OVID), Primo Water (PRMW) and Voyager Therapeutics (VYGR).

(WEI) raised $45 million in an IPO on Thursday, November 15th 2018. The company issued 4,500,000 shares at a price of $9.00-$11.00 per share. Morgan Stanley and Citigroup served as the underwriters for the IPO and AMTD was co-manager.

Weidai trades on the New York Stock Exchange (NYSE) under the ticker symbol "WEI."

Weidai's stock is owned by a number of institutional and retail investors. Top institutional investors include FMR LLC (0.31%) and FMR LLC (0.31%).

WEI stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, and FMR LLC.

Shares of WEI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of WEI stock can currently be purchased for approximately $0.93.

Weidai has a market capitalization of $65.52 million and generates $482.27 million in revenue each year. The company earns $36.43 million in net income (profit) each year or $0.52 on an earnings per share basis. Weidai employs 6,970 workers across the globe.

The official website for Weidai is www.weidai.com.cn.

Weidai's mailing address is NO. 9 BAIYUN ROAD SHANGCHENG DISTRICT, HANGZHOU F4, 310000. The company can be reached via phone at 86-571-5697-9013 or via email at [email protected]